Santaris Pharma

Developer of RNA-targeted therapies for infectious and metabolic diseases

placeCopenhagen, Capital Region Of Denmark, Denmark calendar_todayFounded 2003 groups60 employees language santaris.com

Registered entities

Investor mix

17 investors on record; lead investors include Pfizer, Forbion, Seventure Partners, Sunstone; 3 have since exited.

Investor typeCountShare
Venture capital953%
Private equity212%
Bank & private debt16%
Other / undisclosed529%
Coming soon